1,4-Dioxane → trans-5a',6',7',8',9',9a'-hexahydro-5'H-spiro[piperidine-4,4'-pyrrolo[1,2-a]quinoxaline]
Reaction equation
[CH:1]1[N:5]2[C@H:6]3[C@H:11]([NH:12][C:13]4([CH2:18][CH2:17][N:16](C(OC(C)(C)C)=O)[CH2:15][CH2:14]4)[C:4]2=[CH:3][CH:2]=1)[CH2:10][CH2:9][CH2:8][CH2:7]3.O1CCOCC1>Cl>[CH:1]1[N:5]2[C@H:6]3[C@H:11]([NH:12][C:13]4([CH2:14][CH2:15][NH:16][CH2:17][CH2:18]4)[C:4]2=[CH:3][CH:2]=1)[CH2:10][CH2:9][CH2:8][CH2:7]3Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
trans-tert-Butyl 5a′,6′,7′,8′,9′,9a′-hexahydro-5′H-spiro[piperidine-4,4′-pyrrolo[1,2-a]quinoxaline]-1-carboxylate (0.311 g, 0.901 mmol) was suspended in hydrogen chloride in dioxane (2.0 mL of 4.0 M, 8.0 mmol). The reaction mixture was allowed to stand for 2 hours. The reaction mixture was then evaporated to dryness to give trans-5a′,6′,7′,8′,9′,9a′-hexahydro-5′H-spiro[piperidine-4,4′-pyrrolo[1,2-a]quinoxaline]. ESI-MS m/z calc. 245.2, found 246.3 (M+1)+; Retention time: 0.32 minutes (3 min run).
Workup
- customThe reaction mixture was then evaporated to dryness
Sources & evidence
- ORD record
- ord-3c874922106546ea907a7ae624fb48c1
- Source dataset
- uspto-grants-2014_12
- Patent number
- US08916565B2
Reaction notes
Loading…